|Vanderbilts Dr. W. Kimryn Rathmell to be appointed director of the National Cancer Institute
Kimryn Rathmell MD PhD MMHC the Hugh Jackson Professor of Medicine and chair of the Department of Medicine at Vanderbilt University Medical Center will be appointed Director of the National Cancer Institute.
Friday, November 17th, 2023
|Crowe Osheroff honored by AAMC
Vanderbilts James E. Crowe Jr MD and Neil Osheroff PhD are among 12 individuals honored by the Association of American Medical Colleges during its 2023 Awards Recognition Event.
Monday, October 30th, 2023
|Research Snapshot: DNA replication discovery opens pathways to understanding and treating cancer, aging and degenerative disease
An international collaboration led by biochemist David Cortez reached revelatory conclusions in exploration of how cells tolerate DNA damage and genome instability. Est. reading time: 2 mins.
Tuesday, May 23rd, 2023
|Study explores new urinary tract infection treatment
Vanderbilt's Neil Osheroff, PhD, is part of an international research collaboration resulting in what is on track to be the first new antibiotic treatment for uncomplicated urinary tract infections in more than 20 years.
Thursday, February 23rd, 2023
|Gene network for leukemia factor
Transcription factors — proteins that regulate gene expression — play critical roles in cell fate decisions and are frequent targets of mutation in a variety of human cancers.
Thursday, February 4th, 2021
|A protein that can melt tumors discovered at Vanderbilt
Wednesday, January 27th, 2021
|Cortez named interim chair of the Department of Biochemistry; York named Impossible Foods chief science officer
Tuesday, December 8th, 2020
|Understanding cell division
Tuesday, November 19th, 2019
|Rathmell receives 2019 Eugene P. Schonfeld Award
Wednesday, November 6th, 2019
|Completing DNA synthesis
Monday, October 21st, 2019
|VICC’s Rathmell honored with Louisa Nelson Award
Thursday, October 3rd, 2019
|Team’s study reveals details of new DNA repair pathway
Friday, July 26th, 2019
|International Association of Medical Science Educators honors Osheroff
Thursday, July 11th, 2019
|Potential probe for early ovarian cancer
Saturday, June 29th, 2019
|Researchers putting the brakes on lethal childhood cancer
A recent study suggests that blocking the MYC protein could be “unexpectedly effective” in treating malignant rhabdoid tumor (MRT) is one of the most aggressive and lethal childhood cancers.
Friday, May 3rd, 2019
|The yin and yang of cell signaling
Changes in enzymes involved in lysophospholipid signaling can activate a pathway implicated in development of cancer, a recent study suggests.
Thursday, February 14th, 2019
|HDAC3 role in B-cell development
Histone deacetylases (HDACs) are enzymes that modulate gene expression and have important roles in development and disease. HDAC inhibitors are active against lymphoma, and understanding the roles of specific HDACs is important for further therapeutic development. Scott Hiebert, Ph.
Monday, August 7th, 2017
|Metastatic pancreatic cancer ‘reprograms’ for malignancy
Thursday, January 19th, 2017
|VICC investigators in spotlight at AACR conference
Thursday, May 19th, 2016